GM also, unfortunately, has been hammered on demand for their core business - vehicles - right now. They have surplus manufacturing space and human resources an

GM also, unfortunately, has been hammered on demand for their core business - vehicles - right now. They have surplus manufacturing space and human resources and that may continue for anywhere from a few months to the rest of this year (before perhaps slowly recovering from late 2020 through 2021). It fits quite well in terms of context. The medtech companies need to keep their resources focused on producing medical devices, they are unlikely to have the vast manufacturing capability slack that GM is seeing (some of them may have a bit of increased slack as we turn down elective procedures, delay equipment purchases). The ideal is perhaps to have GM (Ford, etc) working with such companies who can help guide them properly in the medtech manufacturing space, utilizing the best of what both bring to the table. Ford is working with GE, GM is working with Ventec. An interesting Bloomberg article on it: http://archive.is/SLUlj http://archive.is/SLUlj Here is the key response to the parent's questions: "They asked Barra’s team what they needed to make ventilators. GM needed a ventilator-making partner with an established product and a medical sales force." "For his part, Ventec CEO Chris Kiple said that he needed a partner with mass-manufacturing expertise, factories and a workforce to produce on a huge scale to help cities like New York as patients overwhelm hospitals."